CONCORDBIO
NIFTY500
Concord Biotech Ltd.
Pharma · NSE
₹1,173.90
1Y-14.8%
52-week range
₹987 – ₹2,137
From 52w high
-45.1%
RSI (14)
59.8
vs SMA 50 / 200
↑ 50 · ↓ 200
PE
40.4
Forward PE
31.7
ROE
—
Profit margin
27.0%
D/E
0.09
Dividend yield
0.91%
Quality score
34/100
Revenue growth
13.7%
Earnings growth
-16.3%
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.